Frontier Biotech announced that from August 6, 2026 to August 11, 2026, shareholder CHANGJIN WANG reduced its holdings of the company's shares by a total of 2.338,800 shares through centralized bidding and bulk transactions. The number of shares held was reduced from 21.0595 million shares to 18.7287 million shares, accounting for the proportion of 375 million shares in the company's total share capital dropped from 5.6222% to 4.9999%, and changes in equity hit the integer scale lines of 1% and 5%.

Frontier Biotech announced that from August 6, 2026 to August 11, 2026, shareholder CHANGJIN WANG reduced its holdings of the company's shares by a total of 2.338,800 shares through centralized bidding and bulk transactions. The number of shares held was reduced from 21.0595 million shares to 18.7287 million shares, accounting for the proportion of 375 million shares in the company's total share capital dropped from 5.6222% to 4.9999%, and changes in equity hit the integer scale lines of 1% and 5%.